MONIQUE L MANGANELLI ORR
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism FT LAUDERDALE, FL NPI 1659487536
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism FL Corcept Therapeutics All categories
General Payments — all program years on this page
$1,832.36
- Category: General Payments
- Program years: PY2018–2024
- Record count: 83
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $831.09 across 39 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $831.09 | 39 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $116.35 | 6 |
| Novo Nordisk AS | $83.55 | 4 |
| Lilly USA, LLC | $71.20 | 3 |
| Radius Health, Inc. | $64.95 | 2 |
| DEXCOM, INC. | $60.57 | 3 |
| Amgen Inc. | $48.92 | 3 |
| Tandem Diabetes Care, Inc. | $48.30 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47.07 | 2 |
| Abbott Laboratories | $43.00 | 2 |
| BETA BIONICS, INC. | $38.23 | 2 |
| Verity Pharmaceuticals Inc. | $28.32 | 1 |
| SANOFI-AVENTIS U.S. LLC | $28.13 | 1 |
| Neurocrine BioSciences, Inc. | $23.84 | 1 |
| MannKind Corporation | $23.50 | 1 |
| Astellas Pharma US Inc | $23.40 | 1 |
| Esperion Therapeutics, Inc. | $20.08 | 1 |
| CeQur Corporation | $19.20 | 1 |
| ABBVIE INC. | $16.00 | 1 |
| Acella Pharmaceuticals, LLC | $13.38 | 1 |
| TOLMAR, INC. | $13.10 | 1 |
By program year
Records — PY2024 (39)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.